A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
Clinical trial NCT07135973 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07135973
- Sponsor
- Sanofi
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2027-08-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.